Lower Extremity Peripheral Arterial Disease: Less is Sometimes More. Spence M Taylor, M.D.

Similar documents
Chronic lower Extremity Peripheral Arterial Disease: The Relentless Pursuit of Mediocrity

Lower Extremity Peripheral Arterial Disease: Its All About the Pulse. Spence M Taylor, M.D.

Peripheral arterial disease for primary care Ed Aboian, MD

PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014

Practical Point in Diabetic Foot Care 3-4 July 2017

3-year results of the OLIVE registry:

Imaging Strategy For Claudication

Practical Point in Holistic Diabetic Foot Care 3 March 2016

Endovascular Should Be Considered First Line Therapy

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?

Current Vascular and Endovascular Management in Diabetic Vasculopathy

Current Status of Endovascular Therapies for Critical Limb Ischemia

Disclosures. Objectives. Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach. Christopher D. Owens, MD 4/23/2009

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia

Evidence-Based Optimal Treatment for SFA Disease

4/14/2016. How Far Should We Go with the Endovascular Treatment of Advanced PAD in the Era of Health Care Reform?

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome

Angiosome revascularization strategies in real world practice: how much difference does it make?

Critical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017

Case Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN

Endovascular Is The Way To Go: Revascularize As Many Vessels As You Can

Limb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park

Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia

Interventional Treatment First for CLI

PAD Characterization Within A Healthcare System" RAPID Face-to-Face Meeting Schuyler Jones, MD September 14, 2016

Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease

SPINACH Making Limb Salvage Salad from Spinach alone

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

Treatment Strategies For Patients with Peripheral Artery Disease

CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS

Recent Advances in Peripheral Salvage

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge

Easy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012

Vascular screening in diabetic patients: how aggressive should we be and when to intervene?

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery

Surgical Options for revascularisation P E T E R S U B R A M A N I A M

Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts

Will it heal? How to assess the probability of wound healing

Peripheral Arterial Disease: Who has it and what to do about it?

GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE

Global Vascular Guideline on the Management of Chronic Limb Threatening Ischemia -a new foundation for evidence-based care

Peripheral Arterial Disease: A Practical Approach

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step -

Clinical targets and patient outcome goals in BTK intervention

Role of ABI in Detecting and Quantifying Peripheral Arterial Disease

Perfusion Assessment in Chronic Wounds

Multidisciplinary approach to BTK Y. Gouëffic, MD, PhD

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention

Peripheral Vascular Disease

BEST-CLI Trial Study Concept and Current Status

Peripheral Arterial Disease: the growing role of endovascular management

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC

Vascular Surgery Cases: Detours. Brian F. Stull, RDMS, RVT UNC REX Healthcare Vascular Specialists

4/23/2009. Vein Bypass Remains the Gold Standard AND We Can Improve Outcomes. Lower Extremity Revascularization Options: Key Factors to Consider

One Year after In.Pact Deep: Lessons learned from a failed trial. Prof. Dr. Thomas Zeller

Update on BEST-CLI Trial

Hybrid surgical treatment of bilateral aorto-femoral occlusion: a clinical case

Pedal Bypass With Deep Venous Arterialization:

The essentials for BTK procedures: wires, balloons, what else

LIMB SALVAGE IN THE DIABETIC PATIENT

How Do We Optimize the Medical Therapy of Patients with Critical Limb Ischemia?

SAFETY AND EFFECTIVENESS OF ENDOVASCULAR REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIONS

Introduction to Peripheral Arterial Disease. Stacey Clegg, MD Interventional Cardiology August

Introduction. Risk factors of PVD 5/8/2017

DON T LET LEG PAIN BECOME A REAL THREAT.

Infection/ischaemia/amputation: how to build a multidisciplinary center for limb salvage

Clinical Approach to CLI and Related Diagnostics: What You Need to Know

Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria

Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization

North American Society of Cardiovascular Imaging Annual Meeting, Baltimore MD, October 15-18, Tips and Tricks in Vascular Imaging

Angiosome concept myth or truth? Does it make a real difference in real world cases?

Disclosures. Carotid artery stenting. Surveillance after Endovascular Intervention: When to Re-Intervene and What s the Evidence

Registry Assessment of Peripheral Interventional Devices (RAPID)

Disclosures. TASC, AHA, SVS: What s Happening with the Guidelines? How Are They Relevant? Purpose of Practice Guidelines

Intercepting PAD. Playbook for Cardiovascular Care 2018 February 24, Jonathan D Woody, MD, FACS. University Surgical Vascular

NCVH. What's New on the Vascular Horizons? Craig M. Walker, MD, FACC, FACP. New Cardiovascular Horizons

Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC)

Distal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff

Objective assessment of CLI patients Hemodynamic parameters

Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI

Amputation as a Last Resort A Multidisciplinary Approach to Limb Salvage

The Crack and Pave technique for highly resistant calcified lesions. Manuela Matschuck MD University Hospital Leipzig Department Angiology

IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the on-label use of

John E. Campbell, MD. Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)

Garland Green, MD Interventional Cardiologist. Impact of PAD: Prevalence, Risk Factors, Testing, and Medical Management

Case Report Successful Implantation of a Coronary Stent Graft in a Peripheral Vessel

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

Femoropopliteal Above-Knee Bypass: The True Results

What s New in the Management of Peripheral Arterial Disease

Outcomes after endovascular intervention for chronic critical limb ischemia

Nurse and Technician Forum Part II Critical Limb Ischemia: Optimal care, an interdisciplinary challenge

Clinical and social consequences of Buerger disease

In-Stent Restenosis: New Evidence From Laser + Drug Coated Balloons

Transcription:

Lower Extremity Peripheral Arterial Disease: Less is Sometimes More Spence M Taylor, M.D. President, Greenville Health System Clinical University Senior Associate Dean for Academic Affairs and Diversity University of South Carolina School of Medicine Greenville April 28- May 1, 2016 G H S C l i n i c a l U n i v e r s i t y P a r t n e r s

Lower Extremity Peripheral Artery Disease Disclosure Statement World according to Spence Taylor Expert Opinion

3000 Cases/yr Lower extremity ischemia 47.8% of total volume

Standard of Care in 1992 Real opportunity to raise the bar

The case that changed it all

Mrs C. 70 yr old WF-Transferred from out-lying hospital with Lt leg ischemic ulcers blisters from CHF Prolonged course (6 weeks); Home: Died POD # 50 Successful outcome?

Maybe we need to change our approach to the management of critical limb ischemia

Functional outcome not solely determined by limb salvage or reconstruction patency, but by functional, mental, and medical condition at presentation

Claudication CAD Rest Pain Independent Predictors Poor outcome CAD Diabetes ESRD Gangrene Dementia CAD Diabetes ESRD Tissue Loss CAD Diabetes ESRD Gangrene Dementia

Southern Surgical Association 2008 2240 limbs/1732 consecutive patients from Jan. 1998-Dec. 2005 999 limbs/ 663 pts Medically refractory claudication 464 limbs/ 392 pts Rest pain 777 limbs/ 677 pts Tissue loss 60.6% (N=1049) endovascular therapy 38% (N=659) open surgery 1.39% (N= 24) both

Results Secondary Patency

Results Amputation-free Survival

Results Maintenance of Ambulation

Results Maintenance of Independent living

Southern Surgical Association 2008 Implications (General) Outcomes dependent on intrinsic co-morbidities at presentation; not necessarily type of intervention (Endo vs Open) Emphasis: 25% @ 5-yrs Who to treat not How to treat

People go to heaven whether you operate on them or not.. So, when do throw in the towel?

Case Presentation 93 year old female mentally sharp; Prior PTA Assisted living facility; functionally independent Uses legs to transfer; wheelchair bound during the day but very active Baseline congestive heart failure, Diabetes Presents with gangrenous changes, second toe Mrs. H

Case Presentation Slight left knee contracture ABIof 0.39 and a great toe pressure of 13 Triphasic common femoral waveform, superficial femoral artery occlusion with reconstitution of the tibial vessels at midshank Osteomyelitis 2 nd Toe

A Definition of Success Success after Revascularization for Tissue Loss All of the following: 1. Graft patency to the point of wound healing 2. Limb salvage for one year 3. Maintenance of ambulatory status for one year 4. Survival for 6 months Tested on 677 patients (316 endo & 361 open)

Clinical Success Overall = 40.9% Open Bypass = 43.3% Endovascular = 37.0% P =0.06

677 Interventions for Tissue loss Predictors in Probability of Combination Failure (OR) 65-70% Success Impaired ambulation ESRD < 20% Presence of gangrene Success Prior vascular intervention No predictors Independent Predictors Impaired Ambulation, Diabetes, & gangrene Diabetes < 10% Success Impaired Ambulation, ESRD, Diabetes Prior Vasc intervention & Gangrene 35.4% (1.0) 85.2% (10.5) 92.8 (23.7)

Mrs. H: What are my Chances? 70%-80% chance of success (Patency or Limb Salvage) vs. 10%-20% chance of success (Impaired Ambulation, Diabetes, prior PTA & Gangrene > 85% probability of failure [OR 10.5] )

Naysayer s Response: You have to do something. What s the harm in trying endovascular intervention? It is well tolerated and safe, etc, etc, etc.

2015 Medicare Allowable Superficial femoral artery PTA and stent CPT Code Professional Fee Facility Fee 75710-26 75625-26 37226 75960-25 $53.37 $54.14 $506.14 $2,576.46/ or $0 $9,119.70 Total $613.65 $11,696.16 $12,309.81

The Cold Hard Truth Human life is a sexually transmitted disease with a 100% mortality Can not fix a systemic problem with a local operation

If is about the patient and not the anatomy, well consider this 61 year-old man with claudication left leg Cigarette smoker, multiple attempts to quit Seen recently walking around the hospital Works and as informed a contractor, me that likes his to leg hunt is doing well.. Ankle.after brachial index= the balloon.5 angioplasty performed Short segment (5 cm) by his SFA cardiologist occlusion Treatment started exercise & smoking cessation

Where am I missing the boat?

Patients with intermittent claudication have a risk of major amputation of 1% per year and a death rate of 6% per year 6% overall progress to critical limb ischemia Best initial treatment is medical therapy

Claudication - Medical Treatment Stop smoking Exercise program Drug therapy

Claudication - Medical Treatment Exercise Program 34% - can not participate - other ailments 36% - unwilling to participate 30% - participate and do well De La Haye, Vasa, 1992

Mediocrity? At best we help only one-third of our patients with claudication by noninterventional Rx

Summary Self health assessment improved significantly for the overall group, however, the improvement was attributable to the striking improvement in patients with claudication While ambulation and independence rates in patients with CLI exceeded 80% at one year, self health assessment did not improve and amputation-free survival was only 50% Claudication vs. CLI Same pathology; very different diseases

Maybe more is more It s about the patient, not about..

Claudication Do we need to intervene more frequently?

Heresy

1000 Limb Claudication Study Treatment today = predominantly endovascular Rx (> 60%) and safe (< 1% mortality) Symptom resolution = nearly 80%; symptom recurrence = 18% Re-intervention for recurrent symptoms = 6.5%; amputation in this cohort was rare (< 2%)

Secondary Patency n= 1000 93.9% @ 5yrs AIOD better than II

Limb Salvage n= 1000 99% @ 5yrs

Cumulative Survival n=669 77% @ 5yrs

44

Critical Acclaim

You have to admire the fact that this group of surgeons keep track of what they do and try report their results. Unfortunately, the way that report the results is not very useful..not stratified by TASC lesion, pre-and post hemodynamic status, or the occurrence of single or multilevel disease. If you are willing to spend a lot of money, you can treat a lot of patients and not hurt them.

Expert Opinion According to Spence Taylor CLI: Don t miss the forest for the trees. Less may be more Human life is a sexually transmitted disease with 100% mortality It s about the patient: Try to understand when enough is enough & not enough Claudication: Beware of the dogma. It will bite you